Literature DB >> 8147508

A cost-utility analysis of intensive therapy. II: Quality of life in survivors.

S Ridley1, M Biggam, P Stone.   

Abstract

A questionnaire designed to assess changes in quality of life was sent to 56 survivors of critical illness one year after their admission to an intensive therapy unit. Forty-one patients completed the questionnaire, and for the majority, quality of life remained unchanged (n = 25). However significant decreases in quality of life were found in those patients who previously enjoyed a good quality of life or were admitted with respiratory problems. Survivors also recorded significant decreases in five aspects of their perceived quality of life (ability to think and remember, seeing family, their contribution to society, activities outside work and income). As part of a previous study, the costs incurred by each of these patients had been measured so that changes in quality of life detected in this study could be combined to the individual costs and expressed as cost per quality adjusted life year. The cost of intensive therapy for a patient surviving for one year after acute respiratory or cardiovascular disease was 2600 pounds. The total hospital cost per quality adjusted life year was estimated at 7500 pounds, which places intensive therapy at the higher end of health programme costs. If the costs of nonsurvivors are included in the cost per quality adjusted life year calculation, the cost of intensive care increases considerably.

Entities:  

Mesh:

Year:  1994        PMID: 8147508     DOI: 10.1111/j.1365-2044.1994.tb03419.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  6 in total

1.  Expanding our horizons beyond the intensive care unit: does mechanism of lung injury influence the quality of life in ARDS survivors?

Authors:  Salvatore Maurizio Maggiore; Massimo Antonelli
Journal:  Intensive Care Med       Date:  2006-09-07       Impact factor: 17.440

2.  Survival and quality of life after intensive care.

Authors:  M Capuzzo; M Bianconi; P Contu; V Pavoni; G Gritti
Journal:  Intensive Care Med       Date:  1996-09       Impact factor: 17.440

3.  Variable costs of ICU patients: a multicenter prospective study.

Authors:  Carlotta Rossi; Bruno Simini; Luca Brazzi; Giancarlo Rossi; Danilo Radrizzani; Gaetano Iapichino; Guido Bertolini
Journal:  Intensive Care Med       Date:  2006-02-25       Impact factor: 17.440

4.  Implications of ICU triage decisions on patient mortality: a cost-effectiveness analysis.

Authors:  David L Edbrooke; Cosetta Minelli; Gary H Mills; Gaetano Iapichino; Angelo Pezzi; Davide Corbella; Philip Jacobs; Anne Lippert; Joergen Wiis; Antonio Pesenti; Nicolo Patroniti; Romain Pirracchio; Didier Payen; Gabriel Gurman; Jan Bakker; Jozef Kesecioglu; Chris Hargreaves; Simon L Cohen; Mario Baras; Antonio Artigas; Charles L Sprung
Journal:  Crit Care       Date:  2011-02-09       Impact factor: 9.097

Review 5.  Ethics review: 'Living wills' and intensive care--an overview of the American experience.

Authors:  Andrew R J Tillyard
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

6.  Quality of life before admission to the intensive care unit.

Authors:  Nathalia Perazzo Tereran; Suely Sueko Viski Zanei; Iveth Yamaguchi Whitaker
Journal:  Rev Bras Ter Intensiva       Date:  2012-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.